Raghavendra Tirupathi, MD, FACP

Treatments for COVID-19: Update for hospitalists

Author:: Melissa Tiyouh, MD; Divya Tenneti, MD; Raghavendra Tirupathi, MD, FACP; And Raman Palabindala, MD, SFHM

Publish date: November 12, 2020

Currently, there is no clinically proven specific antiviral treatment for COVID-19.

Author:: Raghavendra Tirupathi, MD, FACP; Kavya Bharathidasan, MD; Ruth Freshman, MSN, RN, Cic; Venkataraman Palabindala, MD, SFHM

Publish date: May 19, 2020

Masks alone are not enough to control COVID-19 and must be coupled with other nonpharmacologic interventions.

Author:: Sri Lakshmi Hyndavi Yeruva, MD; Trevor Henderson; Jaffar A. Al-Tawfiq, MD, FACP; Raghavendra Tirupathi, MD, FACP

Publish date: May 7, 2020

Early recognition and anticoagulation is imperative to improve clinical outcomes in COVID-19–associated coagulopathies.

Author:: Bishnu H. Subedi, MD, FACC; Raghavendra Tirupathi, MD, FACP; Swetha Areti Md; And Venkataraman Palabindala, MD, SFHM, MBA

Publish date: April 24, 2020

COVID myocarditis can mimic acute MI or stress cardiomyopathy and will present diagnostic and therapeutic challenges.

Author:: Venkata Konanki, MD, FAAP; Raghavendra Tirupathi, MD, FACP; And Raman Palabindala, MD, SFHM

Publish date: March 17, 2020

Children could be very efficient vectors of COVID-19 and potentially spread the pathogen to vulnerable populations.

Publish date: June 29, 2018

The first step in controlling C. auris is accurate identification.